Nöroimmünolojik Hastalıklarda Temel Laboratuvar Testleri

Abbatemarco JR, Rodenbeck SJ, Day GS, Titulaer MJ, Yeshokumar AK, Clardy SL. Autoimmune neurology: the need for comprehensive care. Neurology: Neuroimmunology & Neuroinflammation. 2021;8(5):e1033.

Clardy SL, Smith TL. Therapeutic approach to autoimmune neurologic disorders. CONTINUUM: Lifelong Learning in Neurology. 2024;30(4):1226-58.

López-Chiriboga AS, Flanagan EP, editors. Diagnostic and therapeutic approach to autoimmune neurologic disorders. Seminars in Neurology; 2018: Thieme Medical Publishers.

Teleanu RI, Niculescu A-G, Vladacenco OA, Roza E, Perjoc R-S, Teleanu DM. The state of the art of pediatric multiple sclerosis. International Journal of Molecular Sciences. 2023;24(9):8251.

Haki M, Al-Biati HA, Al-Tameemi ZS, Ali IS, Al-Hussaniy HA. Review of multiple sclerosis: Epidemiology, etiology, pathophysiology, and treatment. Medicine. 2024;103(8):e37297.

Uzawa A, Oertel FC, Mori M, Paul F, Kuwabara S. NMOSD and MOGAD: an evolving disease spectrum. Nature Reviews Neurology. 2024:1-18.

Zhu Y, Wang B, Hao Y, Zhu R. Clinical features of myasthenia gravis with neurological and systemic autoimmune diseases. Frontiers in immunology. 2023;14:1223322.

Verma N, Jaffer MH, Kolli AS, Mokhtari S, editors. Updates in the Management of Paraneoplastic Syndrome. Seminars in Neurology; 2024: Thieme Medical Publishers, Inc.

Shastri A, Al Aiyan A, Kishore U, Farrugia ME. Immune-mediated neuropathies: pathophysiology and management. International journal of molecular sciences. 2023;24(8):7288.

Rodin RE, Chitnis T. Soluble biomarkers for Neuromyelitis Optica Spectrum Disorders: a mini review. Frontiers in Neurology. 2024;15:1415535.

Carta S, Dinoto A, Capobianco M, Valentino P, Montarolo F, Sala A, et al. Serum biomarker profiles discriminate AQP4 seropositive and double seronegative Neuromyelitis Optica Spectrum disorder. Neurology: Neuroimmunology & Neuroinflammation. 2023;11(1):e200188.

Kümpfel T, Giglhuber K, Aktas O, Ayzenberg I, Bellmann-Strobl J, Häußler V, et al. Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD)–revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management. Journal of Neurology. 2024;271(1):141-76.

Corbali O, Chitnis T. Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease. Frontiers in Neurology. 2023;14:1137998.

Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. The Lancet Neurology. 2023;22(3):268-82.

Forcadela M, Rocchi C, San Martin D, Gibbons EL, Wells D, Woodhall MR, et al. Timing of MOG-IgG testing is key to 2023 MOGAD diagnostic criteria. Neurology: Neuroimmunology & Neuroinflammation. 2023;11(1):e200183.

Deisenhammer F, Bartos A, Egg R, Gilhus NE, Giovannoni G, Rauer S, et al. Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur J Neurol. 2006;13(9):913-22.

Freedman MS, Thompson EJ, Deisenhammer F, Giovannoni G, Grimsley G, Keir G, et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol. 2005;62(6):865-70.

Jesse S, Brettschneider J, Süssmuth SD, Landwehrmeyer BG, von Arnim CA, Ludolph AC, et al. Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases. J Neurol. 2011;258(6):1034-41.

Stangel M, Fredrikson S, Meinl E, Petzold A, Stüve O, Tumani H. The utility of cerebrospinal fluid analysis in patients with multiple sclerosis. Nat Rev Neurol. 2013;9(5):267-76.

Vecchio D, Puricelli C, Virgilio E, Passarelli F, Guida S, Naldi P, et al. Kappa index for multiple sclerosis diagnosis: an accurate biomarker of intrathecal synthesis. J Neurol. 2024;272(1):30.

Ferriz J, Guallart C, Timoneda P, Fandos M, Lopez-Arqueros J, Sierra-Rivera A, et al. Diagnostic approach for multiple sclerosis: optimizing algorithms for intrathecal synthesis of immunoglobulins. Lab Med. 2024.

Sarthou A, Chrétien P, Giorgi L, Chiron A, Leroy C, Horellou P, et al. The kappa free light chains index is an accurate diagnostic biomarker for paediatric multiple sclerosis. Mult Scler. 2024;30(11-12):1436-44.

Monreal E, Fernández-Velasco JI, García-Soidán A, Sainz de la Maza S, Espiño M, Villarrubia N, et al. Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis. Front Immunol. 2023;14:1288169.

Brownlee WJ, Vidal‐Jordana A, Shatila M, Strijbis E, Schoof L, Killestein J, et al. Towards a Unified Set of Diagnostic Criteria for Multiple Sclerosis. Annals of Neurology. 2024.

Mishra AK, Varma A. Myasthenia Gravis: A Systematic Review. Cureus. 2023;15(12):e50017.

Lazaridis K, Tzartos SJ. Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics. Front Immunol. 2020;11:212.

Trakas N, Tzartos SJ. Immunostick ELISA for rapid and easy diagnosis of myasthenia gravis. J Immunol Methods. 2018;460:107-12.

Bokoliya S, Patil S, Nagappa M, Taly A. A Simple, Rapid and Non-Radiolabeled Immune Assay to Detect Anti-AChR Antibodies in Myasthenia Gravis. Lab Med. 2019;50(3):229-35.

Kaminski HJ, Sikorski P, Coronel SI, Kusner LL. Myasthenia gravis: the future is here. J Clin Invest. 2024;134(12).

Trakas N, Zisimopoulou P, Tzartos SJ. Development of a highly sensitive diagnostic assay for muscle-specific tyrosine kinase (MuSK) autoantibodies in myasthenia gravis. J Neuroimmunol. 2011;240-241:79-86.

Pascual-Goñi E, Caballero-Ávila M, Querol L. Antibodies in Autoimmune Neuropathies: What to Test, How to Test, Why to Test. Neurology. 2024;103(4):e209725.

Martín-Aguilar L, Lleixà C, Pascual-Goñi E. Autoimmune nodopathies, an emerging diagnostic category. Curr Opin Neurol. 2022;35(5):579-85.

Gupta P, Mirman I, Shahar S, Dubey D. Growing Spectrum of Autoimmune Nodopathies. Curr Neurol Neurosci Rep. 2023;23(5):201-12.

Ricken G, Schwaiger C, De Simoni D, Pichler V, Lang J, Glatter S, et al. Detection Methods for Autoantibodies in Suspected Autoimmune Encephalitis. Front Neurol. 2018;9:841.

Gilligan M, McGuigan C, McKeon A. Autoimmune central nervous system disorders: Antibody testing and its clinical utility. Clin Biochem. 2024;126:110746.

McKeon A, Pittock SJ. Overview and Diagnostic Approach in Autoimmune Neurology. Continuum (Minneap Minn). 2024;30(4):960-94.

Zekeridou A. Paraneoplastic Neurologic Disorders. Continuum (Minneap Minn). 2024;30(4):1021-51.

Verma N, Jaffer MH, Kolli AS, Mokhtari S. Updates in the Management of Paraneoplastic Syndrome. Semin Neurol. 2024;44(1):36-46.

Binks S, Uy C, Honnorat J, Irani SR. Paraneoplastic neurological syndromes: a practical approach to diagnosis and management. Pract Neurol. 2022;22(1):19-31.